Concepedia

David L. Elion

DL

9

Publications

450

Citations

9

H-Index

2016

Active since

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

David L. Elion is an author at Vanderbilt University specializing in gene expression, chromatin, and transcription factors.

Top concepts

Publications per year

2016–2021

9

Publications

9

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers

David L. Elion, Max E. Jacobson, Donna J. Hicks et al. · Cancer Research · 2018 · 175 citations

Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1

Thomas A. Werfel, David L. Elion, Bushra Rahman et al. · Cancer Research · 2018 · 86 citations · Full text

Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade

Michelle M. Williams, Linus Lee, Donna J. Hicks et al. · Molecular Cancer Research · 2016 · 53 citations · Full text

Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler

Chase M. Woodley, Alexander S. Romer, Jing Wang et al. · Oncogene · 2021 · 33 citations · Full text

, , +11

ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation

Michelle M. Williams, David Vaught, Meghan M. Joly et al. · Breast Cancer Research · 2017 · 26 citations · Full text

Rows per page

1–5 of 9